Oncolytics Biotech Inc. (ONCY) Financials

ONCY Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 33.9 million 12.6 million
2023-06-30 24.1 million 7.3 million
2023-03-31 26.1 million 7.1 million
2022-12-31 27.5 million 8.0 million

ONCY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.4 million 551856
2023-06-30 -6.4 million 182806
2023-03-31 -5.8 million 234309
2022-12-31 -4.4 million 552344

ONCY Net Income

No data available :(

ONCY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 29.4 million - 378205
2023-06-30 18.4 million - 361836
2023-03-31 - - 419095
2022-12-31 23.7 million - 275071

ONCY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 51.4 million
2023-06-30 48.7 million
2023-03-31 46.1 million
2022-12-31 43.0 million

ONCY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 4.3 million 3.8 million -
2023-06-30 - 2.8 million 2.5 million -
2023-03-31 3695 2.6 million 2.4 million -
2022-12-31 545 3.6 million 2.7 million -

ONCY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 75788
2023-06-30 - 72518
2023-03-31 - -
2022-12-31 - 73016

ONCY

Price: $1.17

52 week price:
0.88
3.39

Earnings Per Share: -0.30 USD

P/E Ratio: -2.76

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 110000

Market Capitalization: 86.7 million

Links: